881 related articles for article (PubMed ID: 31268981)
1. Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders.
Baldwin C; Zerofsky M; Sathe M; Troendle DM; Perito ER
Pancreas; 2019 Aug; 48(7):888-893. PubMed ID: 31268981
[TBL] [Abstract][Full Text] [Related]
2. Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.
Pagin A; Sermet-Gaudelus I; Burgel PR
Arch Pediatr; 2020 Feb; 27 Suppl 1():eS25-eS29. PubMed ID: 32172933
[TBL] [Abstract][Full Text] [Related]
3. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
4. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
5. The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case report.
Johns JD; Rowe SM
BMC Gastroenterol; 2019 Jul; 19(1):123. PubMed ID: 31296159
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.
Ooi CY; Durie PR
J Cyst Fibros; 2012 Sep; 11(5):355-62. PubMed ID: 22658665
[TBL] [Abstract][Full Text] [Related]
7. A novel exon duplication of the cystic fibrosis transmembrane conductance regulator in a patient presenting with adult-onset recurrent pancreatitis.
Kopp BT; Pastore MT; Sturm AC; Holtzlander MJ; Westman JA
Pancreas; 2011 Jul; 40(5):773-7. PubMed ID: 21673536
[TBL] [Abstract][Full Text] [Related]
8. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis.
Bishop MD; Freedman SD; Zielenski J; Ahmed N; Dupuis A; Martin S; Ellis L; Shea J; Hopper I; Corey M; Kortan P; Haber G; Ross C; Tzountzouris J; Steele L; Ray PN; Tsui LC; Durie PR
Hum Genet; 2005 Dec; 118(3-4):372-81. PubMed ID: 16193325
[TBL] [Abstract][Full Text] [Related]
9. The diagnosis of cystic fibrosis.
De Boeck K; Vermeulen F; Dupont L
Presse Med; 2017 Jun; 46(6 Pt 2):e97-e108. PubMed ID: 28576637
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitis.
Segal I; Yaakov Y; Adler SN; Blau H; Broide E; Santo M; Yahav Y; Klar A; Lerner A; Aviram M; Ellis I; Mountford R; Shteyer E; Kerem E; Wilschanski M
J Clin Gastroenterol; 2008 Aug; 42(7):810-4. PubMed ID: 18360295
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and genetic analysis of cystic fibrosis transmembrane conductance reseptor-related disease.
Kilinc AA; Alishbayli G; Taner HE; Cokugras FC; Cokugras H
Pediatr Int; 2020 May; 62(5):629-633. PubMed ID: 32003094
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis.
Akshintala VS; Kamal A; Faghih M; Cutting GR; Cebotaru L; West NE; Jennings MT; Dezube R; Whitcomb DC; Lechtzin N; Merlo CA; Singh VK
Pancreatology; 2019 Dec; 19(8):1023-1026. PubMed ID: 31611131
[TBL] [Abstract][Full Text] [Related]
13. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis.
Ooi CY; Dorfman R; Cipolli M; Gonska T; Castellani C; Keenan K; Freedman SD; Zielenski J; Berthiaume Y; Corey M; Schibli S; Tullis E; Durie PR
Gastroenterology; 2011 Jan; 140(1):153-61. PubMed ID: 20923678
[TBL] [Abstract][Full Text] [Related]
14. Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis.
Sofia VM; Surace C; Terlizzi V; Da Sacco L; Alghisi F; Angiolillo A; Braggion C; Cirilli N; Colombo C; Di Lullo A; Padoan R; Quattrucci S; Raia V; Tuccio G; Zarrilli F; Tomaiuolo AC; Novelli A; Lucidi V; Lucarelli M; Castaldo G; Angioni A
Mol Med; 2018 Jul; 24(1):38. PubMed ID: 30134826
[TBL] [Abstract][Full Text] [Related]
15. Pancreatitis and cystic fibrosis gene mutations.
Choudari CP; Lehman GA; Sherman S
Gastroenterol Clin North Am; 1999 Sep; 28(3):543-9, vii-viii. PubMed ID: 10503135
[TBL] [Abstract][Full Text] [Related]
16. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.
Cohn JA; Friedman KJ; Noone PG; Knowles MR; Silverman LM; Jowell PS
N Engl J Med; 1998 Sep; 339(10):653-8. PubMed ID: 9725922
[TBL] [Abstract][Full Text] [Related]
17. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
[TBL] [Abstract][Full Text] [Related]
18. Atypical CF and CF related diseases.
Kerem E
Paediatr Respir Rev; 2006; 7 Suppl 1():S144-6. PubMed ID: 16798544
[TBL] [Abstract][Full Text] [Related]
19. Natural history of pancreatitis associated with cystic fibrosis gene mutations.
Frulloni L; Castellani C; Bovo P; Vaona B; Calore B; Liani C; Mastella G; Cavallini G
Dig Liver Dis; 2003 Mar; 35(3):179-85. PubMed ID: 12779072
[TBL] [Abstract][Full Text] [Related]
20. Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis.
Ratkiewicz M; Pastore M; McCoy KS; Thompson R; Hayes D; Sheikh SI
World J Pediatr; 2017 Apr; 13(2):129-135. PubMed ID: 28194692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
